ursodeoxycholic acid has been researched along with Dyslipidemias in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, T; He, Q; He, Z; Huang, R; Jiang, X; Li, C; Li, S; Liu, X; Wang, Y; Zhang, X | 1 |
| Abu-Hayyeh, S; Borges Manna, L; Chambers, J; Dixon, P; Flaviani, F; Godfrey, KM; Jansen, E; Kitaba, N; Lillycrop, K; Marschall, HU; McIlvride, S; Papacleovoulou, G; Pataia, V; Qadri, A; Vazquez-Lopez, M; Wahlström, A; Williamson, C | 1 |
| Dohmen, K; Haruno, M; Tanaka, H | 1 |
| Boldizhar, P; Derbak, M | 1 |
| Hashizume, H; Horiguchi, N; Hosonuma, K; Kakizaki, S; Kusano, M; Sato, K; Yamada, M; Yamazaki, Y; Yanagisawa, M | 1 |
| Castellaneta, NM; Di Leo, A; Facciorusso, A; Licinio, R | 1 |
| Hosonuma, K; Kusano, M; Sato, K; Yamada, M | 1 |
| Kanno, K; Kishikawa, N; Mizooka, M; Sugiyama, A; Tazuma, S; Yokobayashi, K | 1 |
| Alvaro, D; Attili, AF; Bragazzi, MC; Callea, F; Giubilo, F; Merli, M | 1 |
| Fickert, P; Lackner, C; Marschall, HU; Thorell, A; Trauner, M; Wagner, M; Zollner, G | 1 |
| Premkumar, M; Sable, T | 1 |
| Christie, D; Finn, L; Horslen, S; Suskind, DL; Wahbeh, G | 1 |
| Il'chenko, LIu; Khomeriki, SG; Mel'nikova, NV; Ovsiannikova, ON; Zvenigorodskaia, LA | 1 |
| Khomeriki, SG; Lazebnik, LB; Mel'nikova, NV; Ovsiannikova, ON; Samsonova, NG; Zvenigorodskaia, LA | 1 |
4 trial(s) available for ursodeoxycholic acid and Dyslipidemias
| Article | Year |
|---|---|
[Correction of dyslipidemia in patients with chronic hepatitis C, combined with diabetes type 2].
Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Hepatitis C, Chronic; Humans; Male; Middle Aged; S-Adenosylmethionine; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.
Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Myalgia; Prognosis; Renal Insufficiency; Survival Rate; Time; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients.
Topics: Adult; Dyslipidemias; Fatty Liver; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Obesity, Morbid; Ursodeoxycholic Acid | 2011 |
[Atherogenic dyslipidemia, non-alcohol steatohepatitis, methods of treatment].
Topics: Adult; Aged; Biomarkers; Diet, Atherogenic; Dyslipidemias; Fatty Liver; Female; Humans; Lipids; Liver; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
10 other study(ies) available for ursodeoxycholic acid and Dyslipidemias
| Article | Year |
|---|---|
Capsaicin regulates dyslipidemia by altering the composition of bile acids in germ-free mice.
Topics: Animals; Bile Acids and Salts; Blood Glucose; Capsaicin; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, LDL; Diet, High-Fat; Dyslipidemias; Endotoxins; Glycochenodeoxycholic Acid; Insulins; Interleukin-6; Lipoproteins, HDL; Liver; Mice; Triglycerides; Ursodeoxycholic Acid | 2022 |
Ursodeoxycholic acid improves feto-placental and offspring metabolic outcomes in hypercholanemic pregnancy.
Topics: Adult; Animals; Bile Acids and Salts; Cholestasis, Intrahepatic; Dyslipidemias; Epigenome; Female; Fetus; Humans; Male; Mice; Mice, Inbred C57BL; Placenta; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2020 |
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis.
Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid | 2013 |
Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?
Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid | 2015 |
Response to Licinio et al.
Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid | 2015 |
Long-term administration of a Niemann-Pick C1-like 1 inhibitor, ezetimibe, does not worsen bile lithogenicity in dyslipidemic patients with hepatobiliary diseases.
Topics: Anticholesteremic Agents; Bile; Cholesterol; Dyslipidemias; Ezetimibe; Fatty Liver; Female; Gallstones; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Phytosterols; Ursodeoxycholic Acid | 2016 |
Atorvastatin-induced prolonged cholestasis with bile duct damage.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cholestasis; Dyslipidemias; Heptanoic Acids; Humans; Male; Pyrroles; Ursodeoxycholic Acid | 2010 |
Obesity, dyslipidemia and cholesterol gallstone disease during one year of Antarctic residence.
Topics: Adult; Antarctic Regions; Body Mass Index; Diet; Dyslipidemias; Female; Gallstones; Humans; Male; Middle Aged; Obesity; Ursodeoxycholic Acid | 2012 |
A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Topics: Abnormalities, Multiple; Anticholesteremic Agents; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestyramine Resin; Dyslipidemias; Female; Humans; Ursodeoxycholic Acid | 2006 |
[Cholesterosis of the gall bladder and atherogenic dyslipidemia: etiology, pathogenesis, clinical symptoms, diagnosis and treatment].
Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Cholecystectomy, Laparoscopic; Cholesterol; Diagnosis, Differential; Dyslipidemias; Fatty Liver; Female; Follow-Up Studies; Gallbladder; Gallbladder Diseases; Humans; Male; Middle Aged; Prognosis; Ultrasonography; Ursodeoxycholic Acid | 2008 |